Search

Your search keyword '"Armstrong, Paul W."' showing total 153 results
Start Over Author "Armstrong, Paul W." Publisher ovid technologies (wolters kluwer health)
153 results on '"Armstrong, Paul W."'

1. Abstract 14391: Biomarkers, Proteomics, and Echocardiography Lend Insights into Cardiovascular Death in HFrEF: A VICTORIA Substudy

Author

Shah, Palak, primary, Zheng, Yinggan, additional, Pieske, Burkert, additional, Melenovsky, Vojtech, additional, Lam, Carolyn S, additional, Sliwa, Karen S, additional, Butler, Javed, additional, Ezekowitz, Justin A, additional, deFilippi, Christopher, additional, OConnor, Christopher, additional, Roessig, Lothar, additional, Tromp, Jasper, additional, Westerhout, Cynthia M, additional, Voors, Adriaan A, additional, and Armstrong, Paul W, additional

Published
2023
Full Text
View/download PDF

2. Participation in a Heart Failure Clinical Trial

Author

Ezekowitz, Justin, primary, Mentz, Robert J., additional, Westerhout, Cynthia M., additional, Sweitzer, Nancy K., additional, Givertz, Michael M., additional, Piña, Ileana L., additional, O’Connor, Christopher M., additional, Greene, Stephen J., additional, McMullan, Ciaran, additional, Roessig, Lothar, additional, Hernandez, Adrian F., additional, and Armstrong, Paul W., additional

Published
2021
Full Text
View/download PDF

4. Abstract 13829: Index Event, Clinical Outcomes and Response to Vericiguat in the Victoria Trial

Author

Lam, Carolyn, primary, Sliwa, Karen S, additional, Giczewska, Anna, additional, Anstrom, Kevin, additional, Edelmann, Frank, additional, Refsgaard, Jens, additional, Bocchi, Edimar A, additional, Ezekowitz, Justin, additional, Hernandez, Adrian F, additional, O'Connor, Christopher, additional, ROESSIG, Lothar, additional, Patel, Mahesh J, additional, Pieske, Burkert, additional, and Armstrong, Paul W, additional

Published
2020
Full Text
View/download PDF

5. Abstract 14727: Meteorin-like Glial Cell Differentiation Regulator is a Novel Protein Biomarker of Cardiovascular Outcomes in Patients With Diabetes and Vascular Disease: A TECOS Substudy

Author

Truby, Lauren K, primary, Regan, Jessica A, additional, Nguyen, Maggie, additional, Giamberardino, Stephani, additional, Mentz, Robert J, additional, McGarrah, Robert W, additional, Zheng, Yinggan, additional, McGuire, Darren K, additional, Buse, John B, additional, Armstrong, Paul W, additional, Green, Jennifer, additional, standl, eberhard, additional, Peterson, Eric D, additional, Shah, Svati H, additional, and Holman, Rury, additional

Published
2020
Full Text
View/download PDF

6. Abstract 15589: Mitochondrial Metabolites Predict Cardiovascular Outcomes and Heart Failure in People With Type 2 Diabetes Mellitus and Vascular Disease: A Tecos Substudy

Author

Regan, Jessica A, primary, Green, Jennifer, additional, Truby, Lauren K, additional, Nguyen, Maggie, additional, Giamberardino, Stephanie, additional, Mentz, Robert J, additional, McGarrah, Robert W, additional, Zheng, Yinggan, additional, Buse, John B, additional, McGuire, Darren K, additional, standl, eberhard, additional, Armstrong, Paul W, additional, Holman, Rury R, additional, Peterson, Eric D, additional, and Shah, Svati H, additional

Published
2020
Full Text
View/download PDF

7. Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization

Author

Marquis-Gravel, Guillaume, primary, Neely, Megan L., additional, Valgimigli, Marco, additional, Costa, Francesco, additional, Van Klaveren, David, additional, Altner, Rituparna, additional, Bhatt, Deepak L., additional, Armstrong, Paul W., additional, Fox, Keith A. A., additional, White, Harvey D., additional, Ohman, E. Magnus, additional, and Roe, Matthew T., additional

Published
2020
Full Text
View/download PDF

12. Rationale and Design of the VITALITY-HFpEF Trial

Author

Butler, Javed, primary, Lam, Carolyn S.P., additional, Anstrom, Kevin J., additional, Ezekowitz, Justin, additional, Hernandez, Adrian F., additional, O’Connor, Christopher M., additional, Pieske, Burkert, additional, Ponikowski, Piotr, additional, Shah, Sanjiv J., additional, Solomon, Scott D., additional, Voors, Adriaan A., additional, Wu, Yi, additional, Carvalho, Francine, additional, Bamber, Luke, additional, Blaustein, Robert O., additional, Roessig, Lothar, additional, and Armstrong, Paul W., additional

Published
2019
Full Text
View/download PDF

15. Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

Author

Ungar, Leo, primary, Clare, Robert M., additional, Rodriguez, Fatima, additional, Kolls, Bradley J., additional, Armstrong, Paul W., additional, Aylward, Philip, additional, Held, Claes, additional, Moliterno, David J., additional, Strony, John, additional, Van de Werf, Frans, additional, Wallentin, Lars, additional, White, Harvey D., additional, Tricoci, Pierluigi, additional, Harrington, Robert A., additional, Mahaffey, Kenneth W., additional, and Melloni, Chiara, additional

Published
2018
Full Text
View/download PDF

17. Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points

Author

Greene, Stephen J., primary, Hernandez, Adrian F., additional, Sun, Jie-Lena, additional, Butler, Javed, additional, Armstrong, Paul W., additional, Ezekowitz, Justin A., additional, Zannad, Faiez, additional, Ferreira, João Pedro, additional, Coles, Adrian, additional, Metra, Marco, additional, Voors, Adriaan A., additional, Califf, Robert M., additional, O’Connor, Christopher M., additional, and Mentz, Robert J., additional

Published
2018
Full Text
View/download PDF

21. Interaction of Body Mass Index on the Association Between N‐Terminal‐Pro‐b‐Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)

Author

Bhatt, Ankeet S., primary, Cooper, Lauren B., additional, Ambrosy, Andrew P., additional, Clare, Robert M., additional, Coles, Adrian, additional, Joyce, Emer, additional, Krishnamoorthy, Arun, additional, Butler, Javed, additional, Felker, G. Michael, additional, Ezekowitz, Justin A., additional, Armstrong, Paul W., additional, Hernandez, Adrian F., additional, O'Connor, Christopher M., additional, and Mentz, Robert J., additional

Published
2018
Full Text
View/download PDF

22. Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events

Author

Navar, Ann Marie, primary, Gallup, Dianne S., additional, Lokhnygina, Yuliya, additional, Green, Jennifer B., additional, McGuire, Darren K., additional, Armstrong, Paul W., additional, Buse, John B., additional, Engel, Samuel S., additional, Lachin, John M., additional, Standl, Eberhard, additional, Van de Werf, Frans, additional, Holman, Rury R., additional, and Peterson;, Eric D., additional

Published
2017
Full Text
View/download PDF

24. Relationship Between Arterial Access and Outcomes in ST‐Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study

Author

Shavadia, Jay, Welsh, Robert, Gershlick, Anthony, Zheng, Yinggan, Huber, Kurt, Halvorsen, Sigrun, Steg, Phillipe G., Van de Werf, Frans, Armstrong, Paul W., Kaff, A., Malzer, R., Sebald, D., Glogar, D., Gyöngyösi, M., Weidinger, F., Weber, H., Gaul, G., Chmelizek, F., Seidl, S., Pichler, M., Pretsch, I., Vergion, M., Herssens, M., Van Haesendonck, C., Saraiva, J. F K, Sparenberg, A. L F, Souza, J. A., Moraes, J. B M, Sant'anna, F. M., Tarkieltaub, E., Hansen, J. R., Oliveira, E. M., Leonhard, O., Cantor, W., Senaratne, M., Aptecar, E., Asseman, P., Belle, L., Belliard, O., Berland, J., Berthier, A., Besnard, C., Bonneau, A., Bonnefoy, E., Brami, M., Canu, G., Capellier, G., Cattan, S., Champagnac, D., Chapon, P., Cheval, B., Claudel, J., Cohen Tenoudji, P., Coste, P., Debierre, V., Domergue, R., Echahed, K., El Khoury, C., Ferrari, E., Garrot, P., Henry, P., Jardel, B., Jilwan, R., Julie, V., Ketelers, R., Lapostolle, F., Le Tarnec, J., Livarek, B., Mann, Y., Marchand, X., Pajot, F., Perret, T., Petit, P., Probst, V., Ricard Hibon, A., Robin, C., Salama, A., Salengro, E., Savary, D., Schiele, F., Soulat, L., Tabone, X., Taboulet, P., Thicoïpe, M., Torres, J., Tron, C., Vanzetto, G., Villain-Coquet, L., Piper, S., Mochmann, H. C., Nibbe, L., Schniedermeier, U., Heuer, H., Marx, F., Schöls, W., Lepper, W., Grahl, R., Muth, G., Lappas, G., Mantas, I., Skoumbourdis, E., Dilanas, C., Kaprinis, I., Vogiatzis, I., Zarifis, I., Spyromitros, G., Konstantinides, S., Symeonides, D., Rossi, G. P., Bermano, F., Ferlito, S., Paolini, P., Valagussa, L., Della Rovere, F., Miccoli, F., Chiti, M., Vergoni, W., Comeglio, M., Percoco, G., Valgimigli, M., Berget, K., Skjetne, O., Schartum-Hansen, H., Andersen, K., Rolstad, O. J., Aguirre Zurita, O. N., Castillo León, R. P., Villar Quiroz, A. C., Glowka, A., Kulus, P., Kalinina, S., Bushuev, A., Barbarash, O., Tarasov, N., Fomin, I., Makarov, E., Markov, V., Danilenko, A., Volkova, E., Frolenkov, A., Burova, N., Yakovlev, A., Elchinskaya, L., Boldueva, S., Klein, G., Kolosova, I., Ovcharenko, E., Fairushin, R., Andjelic, S., Vukcevic, V., Neskovic, A., Krotin, M., Rajkovic, T., Pavlovic, M., Perunicic, J., Kovacevic, S., Petrovic, V., Mitov, V., Ruiz, A., García-Alcántara, A., Martínez, M., Díaz, J., Paz, M. A., Manzano, F. L., Martín, C., Macaya, C., Corral, E., Fernández, J. J., Martín, F., García, R., Siriwardena, N., Rawstorne, O., Baumbach, A., Manoharan, G., Menown, I., McHechan, S., and Morgan, D.

Subjects
Male, Epidemiology, medicine.medical_treatment, 030204 cardiovascular system & hematology, Coronary Angiography, 0302 clinical medicine, Recurrence, Odds Ratio, Thrombolytic Therapy, 030212 general & internal medicine, Myocardial infarction, Original Research, Primary percutaneous coronary intervention, Shock, Thrombolysis, Middle Aged, Clopidogrel, Femoral Artery, Tissue Plasminogen Activator, Radial Artery, Cardiology, Female, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, Ticlopidine, Arterial access, Hemorrhage, 03 medical and health sciences, Percutaneous Coronary Intervention, Fibrinolytic Agents, Internal medicine, Catheterization, Peripheral, ST‐segment elevation myocardial infarction, Journal Article, medicine, Humans, Enoxaparin, Mortality, Aged, Heart Failure, Pharmacoinvasive strategy, Aspirin, business.industry, Percutaneous coronary intervention, Odds ratio, medicine.disease, ST-segment elevation myocardial infarction, Clinical trial, Blood pressure, Heart failure, Multivariate Analysis, Conventional PCI, Tenecteplase, ST Elevation Myocardial Infarction, business, Acute Coronary Syndromes, Platelet Aggregation Inhibitors
Abstract

Background The effectiveness of radial access ( RA ) in ST ‐elevation myocardial infarction ( STEMI ) has been predominantly established in primary percutaneous coronary intervention ( pPCI ) with limited exploration of this issue in the early postfibrinolytic patient. The purpose of this study was to compare the effectiveness and safety of RA versus femoral ( FA ) access in STEMI undergoing either a pharmacoinvasive ( PI ) strategy or pPCI . Methods and Results Within ST rategic Reperfusion Early After Myocardial Infarction ( STREAM ), we evaluated the relationship between arterial access site and primary outcome (30‐day composite of death, shock, congestive heart failure, or reinfarction) and major bleeding according to the treatment strategy received. A total of 1820 STEMI patients were included: 895 PI (49.2%; rescue PCI [n=379; 42.3%], scheduled PCI [n=516; 57.7%]) and 925 pPCI (50.8%). Irrespective of treatment strategy, there was comparable utilization of either access site ( FA : PI 53.4% and pPCI 57.6%). FA STEMI patients were younger, had lower presenting systolic blood pressure, lesser Thrombolysis In Myocardial Infarction risk, and more ∑ ST ‐elevation at baseline. The primary composite endpoint occurred in 8.9% RA versus 15.7% FA patients ( P RA persisted (adjusted odds ratio [ OR ], 0.59; 95% CI , 0.44–0.78; P pPCI (adjusted OR , 0.63; 95% CI , 0.43–0.92) and PI cohorts (adjusted OR , 0.57 95% CI , 0.37–0.86; P interaction=0.730). There was no difference in nonintracranial major bleeding with either access group ( RA vs FA , 5.2% vs 6.0%; P =0.489). Conclusions Regardless of the application of a PI or pPCI strategy, RA was associated with improved clinical outcomes, supporting current STEMI evidence in favor of RA in PCI . Clinical Trial Registration URL : https://www.clinicaltrials.gov/ . Unique identifier: NCT 00623623.

Published
2016

25. Lipoprotein‐Associated Phospholipase A 2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Author

Wallentin, Lars, Held, Claes, Armstrong, Paul W., Cannon, Christopher P., Davies, Richard Y., Granger, Christopher B., Hagström, Emil, Harrington, Robert A., Hochman, Judith S., Koenig, Wolfgang, Krug‐Gourley, Sue, Mohler, Emile R., Siegbahn, Agneta, Tarka, Elizabeth, Steg, Philippe Gabriel, Stewart, Ralph A. H., Weiss, Robert, Östlund, Ollie, White, Harvey D., Budaj, Andrzej, Ardissino, Diego, Avezum, Alvaro, Aylward, Philip E., Bryce, Alfonso, Chen, Hong, Chen, Ming‐Fong, Corbalan, Ramon, Dalby, Anthony J., Danchin, Nicolas, De Winter, Robbert J., Denchev, Stefan, Diaz, Rafael, Elisaf, Moses, Flather, Marcus D., Goudev, Assen R., Grinfeld, Liliana, Husted, Steen, Kim, Hyo‐Soo, Linhart, Ales, Lonn, Eva, López‐Sendón, José, Manolis, Athanasios J., Nicolau, José C., Pais, Prem, Parkhomenko, Alexander, Pedersen, Terje R., Pella, Daniel, Ramos‐Corrales, Marco A., Ruda, Mikhail, Sereg, Mátyás, Siddique, Saulat, Sinnaeve, Peter, Sritara, Piyamitr, Swart, Henk P., Sy, Rody G., Teramoto, Tamio, Tse, Hung‐Fat, Weaver, W. Douglas, Viigimaa, Margus, Vinereanu, Dragos, Zhu, Junren, ACS - Amsterdam Cardiovascular Sciences, and Cardiology

Subjects
Male, medicine.medical_specialty, Phospholipase A2 Inhibitors, Myocardial Infarction, Coronary Disease, Coronary Artery Disease, 030204 cardiovascular system & hematology, Coronary artery disease, 03 medical and health sciences, 0302 clinical medicine, stomatognathic system, Double-Blind Method, Risk Factors, Interquartile range, Darapladib, Internal medicine, Oximes, medicine, Coronary Heart Disease, Humans, Prospective Studies, 030212 general & internal medicine, Myocardial infarction, Stroke, Original Research, Aged, Pharmacology, business.industry, Lipoprotein-associated phospholipase A2, lipoprotein, Hazard ratio, respiratory system, Middle Aged, medicine.disease, Treatment, STABILITY Investigators, inflammation, Benzaldehydes, Heart failure, 1-Alkyl-2-acetylglycerophosphocholine Esterase, Cardiology, Female, lipids (amino acids, peptides, and proteins), atherosclerosis, Cardiology and Cardiovascular Medicine, business, Biomarkers
Abstract

Background We evaluated lipoprotein‐associated phospholipase A 2 (Lp‐ PLA 2 ) activity in patients with stable coronary heart disease before and during treatment with darapladib, a selective Lp‐ PLA 2 inhibitor, in relation to outcomes and the effects of darapladib in the STABILITY trial. Methods and Results Plasma Lp‐ PLA 2 activity was determined at baseline (n=14 500); at 1 month (n=13 709); serially (n=100) at 3, 6, and 18 months; and at the end of treatment. Adjusted Cox regression models evaluated associations between Lp‐ PLA 2 activity levels and outcomes. At baseline, the median Lp‐ PLA 2 level was 172.4 μmol/min per liter (interquartile range 143.1–204.2 μmol/min per liter). Comparing the highest and lowest Lp‐ PLA 2 quartile groups, the hazard ratios were 1.50 (95% CI 1.23–1.82) for the primary composite end point (cardiovascular death, myocardial infarction, or stroke), 1.95 (95% CI 1.29–2.93) for hospitalization for heart failure, 1.42 (1.07–1.89) for cardiovascular death, and 1.37 (1.03–1.81) for myocardial infarction after adjustment for baseline characteristics, standard laboratory variables, and other prognostic biomarkers. Treatment with darapladib led to a ≈65% persistent reduction in median Lp‐ PLA 2 activity. There were no associations between on‐treatment Lp‐ PLA 2 activity or changes of Lp‐ PLA 2 activity and outcomes, and there were no significant interactions between baseline and on‐treatment Lp‐ PLA 2 activity or changes in Lp‐ PLA 2 activity levels and the effects of darapladib on outcomes. Conclusions Although high Lp‐ PLA 2 activity was associated with increased risk of cardiovascular events, pharmacological lowering of Lp‐ PLA 2 activity by ≈65% did not significantly reduce cardiovascular events in patients with stable coronary heart disease, regardless of the baseline level or the magnitude of change of Lp‐ PLA 2 activity. Clinical Trial Registration URL : https://www.clinicaltrials.gov . Unique identifier: NCT 00799903.

Published
2016

26. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

Author

Antman, Elliott M., Hand, Mary, Armstrong, Paul W., Bates, Eric R., Green, Lee A., Halasyamani, Lakshmi K., Hochman, Judith S., Krumholz, Harlan M., Lamas, Gervasio A., Mullany, Charles J., Pearle, David L., Sloan, Michael A., Smith, Sidney C., Anbe, Daniel T., Kushner, Frederick G., Ornato, Joseph P., Jacobs, Alice K., Adams, Cynthia D., Anderson, Jeffrey L., Buller, Christopher E., Creager, Mark A., Ettinger, Steven M., Halperin, Jonathan L., Hunt, Sharon A., Lytle, Bruce W., Nishimura, Rick, Page, Richard L., Riegel, Barbara, Tarkington, Lynn G., and Yancy, Clyde W.

Subjects
medicine.medical_specialty, medicine.diagnostic_test, Task force, business.industry, Adrenergic beta-Antagonists, Myocardial Infarction, Anticoagulants, Disease Management, Myocardial Reperfusion, American Heart Association, Canadian Cardiovascular Society, Combined Modality Therapy, St elevation myocardial infarction, Physiology (medical), Internal medicine, medicine, Door-to-balloon, Physical therapy, Cardiology, Myocardial infarction diagnosis, Angioplasty, Balloon, Coronary, Cardiology and Cardiovascular Medicine, business, Electrocardiography, Platelet Aggregation Inhibitors
Published
2008

28. Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

Author

Pagidipati, Neha J., primary, Navar, Ann Marie, additional, Pieper, Karen S., additional, Green, Jennifer B., additional, Bethel, M. Angelyn, additional, Armstrong, Paul W., additional, Josse, Robert G., additional, McGuire, Darren K., additional, Lokhnygina, Yuliya, additional, Cornel, Jan H., additional, Halvorsen, Sigrun, additional, Strandberg, Timo E., additional, Delibasi, Tuncay, additional, Holman, Rury R., additional, and Peterson, Eric D., additional

Published
2017
Full Text
View/download PDF

30. Abstract 13158: Hospitalization for De Novo versus Worsening Chronic Heart Failure: Insights From the ASCEND-HF Trial

Author

Greene, Stephen J, primary, Hernandez, Adrian F, additional, Dunning, Allison, additional, Ambrosy, Andrew P, additional, Armstrong, Paul W, additional, Butler, Javed, additional, Cerbin, Lukasz, additional, Coles, Adrian, additional, Ezekowitz, Justin A, additional, Metra, Marco, additional, Starling, Randall C, additional, Teerlink, John R, additional, Voors, Adriaan A, additional, O’Connor, Christopher M, additional, and Mentz, Robert J, additional

Published
2016
Full Text
View/download PDF

31. Relationship of Platelet Reactivity With Bleeding Outcomes During Long‐Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non‐ST‐Segment Elevation Acute Coronary Syndromes

Author

Cornel, Jan H., primary, Ohman, E. Magnus, additional, Neely, Benjamin, additional, Jakubowski, Joseph A., additional, Bhatt, Deepak L., additional, White, Harvey D., additional, Ardissino, Diego, additional, Fox, Keith A.A., additional, Prabhakaran, Dorairaj, additional, Armstrong, Paul W., additional, Erlinge, David, additional, Tantry, Udaya S., additional, Gurbel, Paul A., additional, and Roe, Matthew T., additional

Published
2016
Full Text
View/download PDF

32. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points

Author

Greene, Stephen J., primary, Hernandez, Adrian F., additional, Sun, Jie-Lena, additional, Metra, Marco, additional, Butler, Javed, additional, Ambrosy, Andrew P., additional, Ezekowitz, Justin A., additional, Starling, Randall C., additional, Teerlink, John R., additional, Schulte, Phillip J., additional, Voors, Adriaan A., additional, Armstrong, Paul W., additional, O’Connor, Christopher M., additional, and Mentz, Robert J., additional

Published
2016
Full Text
View/download PDF

33. Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis

Author

Popma, Christopher J., primary, Sheng, Shi, additional, Korjian, Serge, additional, Daaboul, Yazan, additional, Chi, Gerald, additional, Tricoci, Pierluigi, additional, Huang, Zhen, additional, Moliterno, David J., additional, White, Harvey D., additional, Van de Werf, Frans, additional, Harrington, Robert A., additional, Wallentin, Lars, additional, Held, Claes, additional, Armstrong, Paul W., additional, Aylward, Philip E., additional, Strony, John, additional, Mahaffey, Kenneth W., additional, and Gibson, C. Michael, additional

Published
2016
Full Text
View/download PDF

34. Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non–ST-Segment–Elevation Acute Coronary Syndromes Clinical Trials

Author

Kragholm, Kristian, primary, Goldstein, Sarah A., additional, Yang, Qinghong, additional, Lopes, Renato D., additional, Schulte, Phillip J., additional, Bernacki, Gwen M., additional, White, Harvey D., additional, Mahaffey, Kenneth W., additional, Giugliano, Robert P., additional, Armstrong, Paul W., additional, Harrington, Robert A., additional, Tricoci, Pierluigi, additional, Van de Werf, Frans, additional, Alexander, John H., additional, Alexander, Karen P., additional, and Newby, L. Kristin, additional

Published
2016
Full Text
View/download PDF

35. Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

Author

van Diepen, Sean, primary, Tricoci, Pierluigi, additional, Podder, Mohua, additional, Westerhout, Cynthia M., additional, Aylward, Philip E., additional, Held, Claes, additional, Van de Werf, Frans, additional, Strony, John, additional, Wallentin, Lars, additional, Moliterno, David J., additional, White, Harvey D., additional, Mahaffey, Kenneth W., additional, Harrington, Robert A., additional, and Armstrong, Paul W., additional

Published
2015
Full Text
View/download PDF

36. Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT‐4)

Author

Ezekowitz, Justin A., primary, Welsh, Robert C., additional, Weiss, Dale, additional, Chan, Michael, additional, Keeble, William, additional, Khadour, Fadi, additional, Sharma, Sanjay, additional, Tymchak, Wayne, additional, Sookram, Sunil, additional, Brass, Neil, additional, Knapp, Darren, additional, Koshy, Thomas L., additional, Zheng, Yinggan, additional, and Armstrong, Paul W., additional

Published
2015
Full Text
View/download PDF

37. Abstract 16600: Unraveling Outcomes in Medically Managed Patient With Acute Coronary Syndromes (ACS): The Alberta COntemporary Acute coronary syndrome Patients invasive Treatment Strategies (COAPT) Study

Author

Welsh, Robert C, primary, Bainey, Kevin R, additional, Norris, Colleen, additional, Knudtson, Merril, additional, Traboulsi, Dean, additional, Brass, Neil, additional, Savu, Anamaria, additional, Ali, Imtiaz, additional, O'Neill, Blair, additional, Armstrong, Paul W, additional, and Kaul, Padma, additional

Published
2015
Full Text
View/download PDF

38. Abstract 12243: Associations Between Physical Activity and Prognostic Biomarkers in Patients With Stable Coronary Heart Disease in the STABILITY Trial

Author

Held, Claes, primary, Stewart, Ralph A, additional, Armstrong, Paul W, additional, Cannon, Christopher P, additional, Hadziosmanovic, Nermin, additional, Hagström, Emil, additional, Hochman, Judith S, additional, Koenig, Wolfgang, additional, Lonn, Eva, additional, Nicolau, Jose, additional, Siegbahn, Agneta, additional, Steg, Philippe Gabriel, additional, Watson, David, additional, White, Harvey D, additional, and Wallentin, Lars, additional

Published
2015
Full Text
View/download PDF

40. Abstract 13594: Impact on Clinical Outcomes of Randomization at Community Hospitals Versus Pre-hospital location in STEMI Patients: Insights From the STREAM Study

Author

Welsh, Robert C, primary, Goldstein, Patrick, additional, Carvalho, Antonio, additional, Ostojic, Miodrag C, additional, Nanas, John, additional, Zheng, Yinggan, additional, Gershlick, Anthony, additional, Danays, Thierry, additional, Van de Werf, Frans, additional, and Armstrong, Paul W, additional

Published
2015
Full Text
View/download PDF

41. Abstract 13864: Associations Between the Amount and Intensity of Physical Activity and Major Cardiovascular Events in Patients With Stable Coronary Heart Disease: Results From the STABILITY Trial

Author

Stewart, Ralph A, primary, Held, Claes, additional, Armstrong, Paul W, additional, Cannon, Christopher P, additional, Hadziosmanovic, Nermin, additional, Hagström, Emil, additional, Hochman, Judith S, additional, Koenig, Wolfgang, additional, Lonn, Eva, additional, Nicolau, Jose, additional, Steg, Philippe Gabriel, additional, Watson, David, additional, Wallentin, Lars, additional, and White, Harvey D, additional

Published
2015
Full Text
View/download PDF

42. Abstract 17304: Sudden Cardiac Death After Acute Heart Failure Hospitalization: Insights From ASCEND-HF

Author

Pokorney, Sean, primary, Al-Khatib, Sana M, additional, Sun, Jie-Lena, additional, Schulte, Phillip, additional, O'Connor, Christopher M, additional, Teerlink, John R, additional, Armstrong, Paul W, additional, Ezekowitz, Jusitn A, additional, Starling, Randall C, additional, Voors, Adriaan A, additional, Velazquez, Eric C, additional, Hernandez, Adrian F, additional, and Mentz, Robert J, additional

Published
2015
Full Text
View/download PDF

43. Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND‐HF) Trial

Author

Abualnaja, Seraj, primary, Podder, Mohua, additional, Hernandez, Adrian F., additional, McMurray, John J. V., additional, Starling, Randall C., additional, O'Connor, Christopher M., additional, Califf, Robert M., additional, Armstrong, Paul W., additional, and Ezekowitz, Justin A., additional

Published
2015
Full Text
View/download PDF

44. Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST‐Segment Elevation Myocardial Infarction?

Author

Shavadia, Jay, primary, Zheng, Yinggan, additional, Dianati Maleki, Neda, additional, Huber, Kurt, additional, Halvorsen, Sigrun, additional, Goldstein, Patrick, additional, Gershlick, Anthony H., additional, Wilcox, Robert, additional, Van de Werf, Frans, additional, and Armstrong, Paul W., additional

Published
2015
Full Text
View/download PDF

45. Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non–ST-Segment Elevation Acute Coronary Syndrome Patients

Author

Kragholm, Kristian, primary, Halim, Sharif A., additional, Yang, Qinghong, additional, Schulte, Phillip J., additional, Hochman, Judith S., additional, Melloni, Chiara, additional, Mahaffey, Kenneth W., additional, Moliterno, David J., additional, Harrington, Robert A., additional, White, Harvey D., additional, Armstrong, Paul W., additional, Ohman, E. Magnus, additional, Van de Werf, Frans, additional, Tricoci, Pierluigi, additional, Alexander, John H., additional, Giugliano, Robert P., additional, and Newby, L. Kristin, additional

Published
2015
Full Text
View/download PDF

46. Meta‐Analysis of Intracranial Hemorrhage in Acute Coronary Syndromes: Incidence, Predictors, and Clinical Outcomes

Author

Mahaffey, Kenneth W., primary, Hager, Rebecca, additional, Wojdyla, Daniel, additional, White, Harvey D., additional, Armstrong, Paul W., additional, Alexander, John H., additional, Tricoci, Pierluigi, additional, Lopes, Renato D., additional, Ohman, E. Magnus, additional, Roe, Matthew T., additional, Harrington, Robert A., additional, and Wallentin, Lars, additional

Published
2015
Full Text
View/download PDF

47. Magnitude of Troponin Elevation and Long-Term Clinical Outcomes in Acute Coronary Syndrome Patients Treated With and Without Revascularization

Author

Bagai, Akshay, primary, Huang, Zhen, additional, Lokhnygina, Yuliya, additional, Harrington, Robert A., additional, Armstrong, Paul W., additional, Strony, John, additional, White, Harvey D., additional, Leonardi, Sergio, additional, Held, Claes, additional, Van de Werf, Frans, additional, Wallentin, Lars, additional, Tricoci, Pierluigi, additional, and Mahaffey, Kenneth W., additional

Published
2015
Full Text
View/download PDF

49. Abstract 13846: The Relationship of Platelet Function Measurements with Bleeding Outcomes During Long-term Treatment with Dual Antiplatelet Therapy in Medically Managed NSTE-ACS Patients

Author

Cornel, Jan H, primary, Ohman, E. M, additional, Neely, Benjamin, additional, Jakubowski, Joseph A, additional, Bhatt, Deepak L, additional, White, Harvey D, additional, Ardissino, Diego, additional, Fox, Keith A, additional, Prabhakaran, Dorairaj, additional, Armstrong, Paul W, additional, Erlinge, David, additional, Gurbel, Paul A, additional, and Roe, Matthew T, additional

Published
2014
Full Text
View/download PDF

50. Abstract 14658: Comparative Effectiveness of Torsemide versus Furosemide in Acute Heart Failure Patients: Insights from ASCEND-HF

Author

Mentz, Robert J, primary, Hasselblad, Vic, additional, DeVore, Adam D, additional, Armstrong, Paul W, additional, Ezekowitz, Justin A, additional, Tang, W.H. Wilson, additional, Voors, Adriaan A, additional, Metra, Marco, additional, Hernandez, Adrian F, additional, Califf, Robert M, additional, Anstrom, Kevin J, additional, Velazquez, Eric J, additional, and O’Connor, Christopher M, additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results